FDA OKs another Pfizer, Moderna COVID booster for 50 and up
U.S. regulators today authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds. The Food and Drug Administration's decision opens a fourth dose of the Pfizer or Moderna vaccines to those people ...